Publications by authors named "J Chesney"

Claim this Profile
R
Reduction of Erroneous ST-segment Elevation Myocardial Infarction Diagnoses: A Successful Nurse-led Quality Improvement Project.
John Porter, Aaron B Klassen, Julie A Chesney, Marcia J Wilson, Susan C Eastman

Comput Inform Nurs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).
Michael K Wong, Mohammed M Milhem, Joseph J Sacco, Judith Michels, Gino K In, Jason A Chesney

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors.
Harriet Kluger, Götz Ulrich Grigoleit, Sajeve Thomas, Evidio Domingo-Musibay, Jason A Chesney

Cancer Commun (Lond)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes in Stage III to IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic Disparities.
Shreyas Kalantri, Pranali Pachika, Tyler Jones, Maiying Kong, Goetz Kloecker, Jason Chesney

JCO Oncol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081.
Greg Durm, Hirva Mamdani, Sandra Althouse, Susan Perkins, Salma K Jabbour, Jason Chesney

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis